TNF-α, TNF-β, IL-6, and IL-10 polymorphisms in patients with lung cancer

Disease Markers

Volumn 21, Issue 3, 2005, Pages 157-165

  Seifart, Carola ^a   Plagens, Alexandra ^a   Dempfle, Astrid ^a   Clostermann, Ursula ^a   Vogelmeier, Claus ^a   Von Wichert, Peter ^a   Seifart, Ulf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; INTRON; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK;

EID: 27644542776     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/707131     Document Type: Article

References (47)

1. A. Agudo, W. Ahrens, E. Benhamou, S. Benhamou, P. Boffetta, S.C. Darby, F. Forastiere, C. Fortes, V. Gaborieau, C.A. Gonzalez, K.H. Jockel, M. Kreuzer, F. Merletti, H. Pohlabeln, L. Richiardi, E. Whitley, H.E. Wichmann, P. Zainbon and L. Simonato, Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe, International Journal of Cancer 88 (2000), 820-827.
2. C. Amos, W. Xu and M. Spitz, Is there a genetic basis for lung cancer susceptibility? Recent Results in Cancer Research (1999), 1513-1512.
3. J. Arias-Díaz, E. Vara, J. Torres-Melero, C. García, W. Baki, J.A. Ramírez-Armengol and J.L. Balibrea, Nitrite/Nitrate and Cytokine Levels in Bronchoalveolar Lavage Fluid of Lung Cancer Patients, Cancer 74 (1994), 1546-1551.
4. J. Askling, J. Grunewald, A. Eklund, G. Hillerdal and A. Ekbom, Increased risk for cancer following sarcoidosis, American Journal of Respiratory and Critical Care Medicine 160(5 Pt 1) (1999), 1668-1672.
5. A.K. Bauer, A.M. Malkinson and S.R. Kleeberger, Susceptability to neoplastic and non-neoplastic pulmonary disease in mice: genetic similarities, Am J Physiol Lung Cell Mol Physiol 287 (2004), L685-L703.
6. H. Bernert, K. Sekikawa, R.A. Radcliffe, F. Iraqi, M. You and A.M. Malkinson, TNF-α and IL-10 deficiencies have contrasting effects on lung tumor susceptibility: gender-dependent modulation of IL-10 haploinsufficiency, Mol Carcinog 38(3) (2003), 117-123.
7. S. Boehringer, J.T. Epplen and M. Krawczak, Genetic association studies of bronchial asthma - a need for Bonferroni correction? Human Genetics 107(2) (2000), 197.
8. Y.M. Chen, W.K. Yang, J. Whang-Peng, C.M. Tsai and R.P. Perng, An analysis of cytokine status in serum and effusions of patients with tuberculous and lung cancer, Lung Cancer 31(1) (2001), 25-30.
9. F. de Vita, M. Orditura, G. Galizia, C. Romano, A. Roscigno, E. Lieto and G. Catalano, Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients, Chest 117(2) (2000), 365-373.
10. R. de Waal Malefyt, J. Abrams, B. Benett, C.G. Figdor and J. de Vries, Interleukin 10 (IL-10) inhibits cytokine synthesis by human monozytes: An autoregulatory role of IL-10 produced by monocytes, Journal Experimental Medicine 174 (1991), 1209-1220.
11. G. Davey Smith and S. Ebrahim, 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32 (2003), 1-22.
12. C. Donger, J.L. Georges, V. Nicaud, C. Morrison, A. Evans, F. Kee, D. Arveiler, L. Tiret and F. Cambien, New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction, Eur J Clin Invest 31(1) (2001), 9-15.
13. J. Eskdale, G. Gallagher, C.L. Verweij, V. Keijsers, R.G. Westendorp and T.W. Huizinga, Interleukin 10 secretion in relation to human 11-10 locus haplotypes, Proceedings National Academy of Sciences USA 95 (1998), 9465-9470.
14. D. Fishman, G. Faulds, R. Jeffrey, V. Mohamed-Ali, J.S. Yudkin, S. Humphries and P. Woo, The effect of novel polymorphisms in the interleukin 6 (IL-6) gene on IL-6 transcription and plasma levels, and an association with systemic-onset juvenil chronic arthritis, Journal of Clinical Investigation 102(7) (1998), 1369-1376.
15. H.F. Galley, P.R. Lowe, R.L. Carmichael and N.R. Webster, Genotype and interleukin-10 responses after cardiopulmonary bypass, British Journal of Anaesthesia 91 (2003), 424-426.
16. Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, National Institutes of Health (2001), 2701.
17. A. Hagenbaugh, S. Sharma, S.M. Dubinett, S.H.-Y Wei, R. Aranda, H. Cheroutre, D.J. Fowell, S. Binder, B. Tsao, R.M. Locksley, K.W. Moore and M. Kronenberg, Altered immune response in interleukin transgenic mice, J Exp Med 185(12) (1997), 2101-2110.
18. A.H. Hajeer, M. Lazarus, D. Turner, R.A. Mageed, J. Vencovsky, P. Sinnott, I.V. Hutchinson and WE. Ollier, Il-10 promoter polymorphisms in rheumatoid arthritis, Scandinavian Journal of Rheumatology 27(2) (1998), 142-145.
19. H. Hatanaka, Y. Abe, T. Kamiya, F. Morino, J. Nagata, T. Tokunaga, Y. Oshika, H. Suemizu, H. Kijima, T. Tsuchida, H. Yamakazi, H. Inoue, M. Nakamura and Y. Ueyama, Clinical implications of interleukin (IL)-10 induced by non-small cell lung cancer, Anneals of Oncology 11 (2000), 815-819.
20. H. Hatanaka, Y. Abe, M. Naruke, T. Tokunaga, Y. Oshika, T. Kawakami, H. Osada, J. Nagata, J. Kamochi, T. Tsuchida, H. Kijima, H. Yamakazi, H. Inoue, Y. Ueyama and M. Nakamura, Significant correlation between Interleukin 10 expression and vascularization through Angiopoietin/TIE2 Networks in Non-small cell lung cancer, Clinical Cancer Research 71 (2001), 287-1292.
21. M. Howard, A. O'Garra, H. Ishida, R. de Waal Malefyt and J. de Vries, Biological properties of interleukin-10, Journal of Clinical Immunology 12 (1992), 239-247.
22. M. Huang, J. Wang, P. Lee, S. Sharma, J.T. Mao, H. Meissner, K. Uyemura, R. Modlin, J. Wollman and S.M. Dubinett, Human non-small cell lung cancer express a type 2 cytokine pattern, Cancer Research 55 (1995), 3847-3853.
23. M. Huang, S. Sharma, J.T. Mao and S.M. Dubinett, Non-small cell lung cancer derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production, J Immunol 157 (1996), 5512-5520.
24. M. Lazarus, A.H. Hajeer, D. Turner, P. Sinnott, J. Worthington, W.E. Ollier and I.V. Hutchinson, Genetic variation in the interleukin 10 promoter and systemic lupus erythematosus, J Rheumatol 24 (1997), 2314-2317.
25. S. Lim, E. Crawley, P. Woo and P.J. Barnes, Haplotype associated with low interleukin-10 production in patients with severe asthma, Lancet 35 (1998), 2113.
26. S. Lim, N. Roche, B.G. Oliver, W. Mattos, P.J. Barnes and K. Fan Chung, Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease fromalveolar macrophages in cigarette smokers. Regulation by interleukin-10, American Journal of Respiratory and Critical Care Medicine 162 (Oct. 2000), 1355-1360.
27. J. Little and M.J. Khoury, Mendelian randomisation: a new spin or real progress? Lancet 362(9388) (2003), 930-931.
28. A. Malkinson, A. Bauer, A. Meyer, L. Dwyer-Nield, K. Koski, R. Keith, M. Geraci and Y. Miller, Experimental evidence from an animal model of Adenocarcinoma that chronic inflammation enhances lung cancer risk, Chest 117(5 Suppl 1) (2000), 228S.
29. G. Messer, U. Spengler, M.C. Jung, G. Honold, K. Blomer, G.R. Pape, G. Riethmüller and E.H. Weiss, Polymorphic structure of tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of human TNF-β gene correlates with a variant amino acid position in position 26 and a reduced level of TNF-β production, Journal of Experimental Medicine 173 (1991), 209-219.
30. T.R. Mosmann, J.H. Schumacher, N.F. Street, R. Budd, A. O'Garra, T.A. Fong, M.W. Bond, K.W. Moore, A. Sher and D.F. Fiorentino, Diversity of cytokine synthesis and function of mouse CD4+ cells, Immunological Review 123 (1991), 209-229.
31. D.R. Nyholt, Genetic case-control association studies - correcting for multiple testing, Human Genetics 109(5) (2001), 564-567.
32. O. Olomolaiye, N.A. Wood and J.L. Bidwell, A novel Nla III polymorphism in the human IL-6 promoter, European Journal of Immunogenetics 25(2-3) (1998), 267.
33. T. Petty, Lung cancer and chronic obstructive pulmonary disease, Hematol Oncol Clin North Am 11(3) (1997), 531-541.
34. J.K. Pritchard and N.A. Rosenberg, Use of unlinked genetic markers to detect population stratification in association studies, Am J Hum Genet 65(1) (1999), 220-228.
35. E. Reuss, R. Fimmers, A. Kruger, C. Becker, C. Rittner and T. Hohler, Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study, Genes Immunology 3(7) (2002), 407-413.
36. N. Risch and N. Merikangas, The future of genetic studies of complex human diseases, Science 13(213) (1996), 1516-1517.
37. T. Schimura, M. Hagihara, B. Munkhbat, T. Odaka, H. Kato, Y. Nagamachi and K. Tsuji. The study of tumor necrosis factor beta gene polymorphism in lung cancer patients, Cancer 73(4) (1994), 1184-1188.
38. C. Seifart, A. Dempfle, A. Plagens, U. Seifart, C. Vogelmeier and P. von Wiehert, TNF-, TNF-, IL-6 and IL-10 promoter polymorphisms in patients with chronic obstructive pulmonary disease, Tissue Antigens 65(1) (2005), 93-100.
39. D. Skillrud, D. Offord and R. Miller, Higher risk of lung cancer in chronic obstructive pulmonary disease: A prospective, matched, controlled study, Anneals Internal Medicine (1986), 105503.
40. A. Suarez, P. Castro, R. Alonso, L. Mozo L and C. Gutierrez, Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms, Transplantation 15(75(5)) (2003), 711-717.
41. N. Sueoka, M. Suganuma, E. Sueoka, S. Okabe, S. Matsuyama, K. Imai, K. Nakachi and H.A. Fujiki, new function of green tea: prevention of lifestyle-related diseases, Anneals New York Academy of Sciences 928 (2001), 274-280.
42. A. Tagore, W.M. Gonsalkorale, V. Pravica, A.H. Hajeer, R. McMahon and P.J. Whorwell, Interleukin-10 (IL-10) genotypes in inflammatory bowel disease, Tissue Antigens 54 (1999), 386-390.
43. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott and I.V. Hutchinson, An investigation of polymorphism in the interleukin-10 gene promoter, European Journal of Immunogenetics (1997), 241-248.
44. M. Urosevic and R. Dummer, HLA-G and IL-10 expression in human cancer-different stories with the same message, Semin Cancer Biol 13(5) (2003), 337-342.
45. P. Wang, P. Wu, M.I. Siegel, R.W. Egan and M.M. Billah, IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells, Journal of Immunology 153 (1994), 811-816.
46. A.G. Wilson, F.S. di Giovine, A.I.F. Blakemore and G.W. Duff, Single base polymorphism in the human Tumor necrosis Factor alpha (TNF-α) gene detectable by NcoI restriction of PCR product, Human Molecular Genetics 1(5) (1989), 353.
47. A.G. Wilson, I.A. Symons, T.L. McDowell, H.O. McDevitt and G.W. Duff, Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation, Proceedings National Academy of Sciences USA 94(7) (1997), 3195-3199.